Literature DB >> 23238460

The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs.

Karolina M Stępień1, Michał Tomaszewski, Joanna Tomaszewska, Stanisław J Czuczwar.   

Abstract

This review provides an overview of the knowledge on P-glycoprotein (P-gp) and its role as a membrane transporter in drug resistance in epilepsy and drug interactions. Overexpression of P-gp, encoded by the ABCB1 gene, is involved in resistance to antiepileptic drugs (AEDs), limits gastrointestinal absorption and brain access of AEDs. Although several association studies on ABCB1 gene with drug disposition and disease susceptibility are completed to date, the data remain unclear and incongruous. Although the literature describes other multidrug resistance transporters, P-gp is the main extensively studied drug efflux transporter in epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238460     DOI: 10.1016/s1734-1140(12)70900-3

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  21 in total

Review 1.  Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.

Authors:  Maria D Donovan; Geraldine B Boylan; Deirdre M Murray; John F Cryan; Brendan T Griffin
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

Review 2.  Genetic biomarkers in epilepsy.

Authors:  Yvonne G Weber; Anne T Nies; Matthias Schwab; Holger Lerche
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 3.  Seizures in oligodendroglial tumors.

Authors:  Melissa Kerkhof; Christa Benit; Alberto Duran-Pena; Charles J Vecht
Journal:  CNS Oncol       Date:  2015-10-19

4.  P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?

Authors:  Barry E Gidal
Journal:  Epilepsy Curr       Date:  2014-05       Impact factor: 7.500

5.  Reversal effect of BM-cyclin 1 on multidrug resistance by down-regulating MRP2 in BALB/C nude mice bearing C-A120 cells.

Authors:  Lin Wang; Xiaoyun Li; Gaofeng Jiang; Jizhen Liang; Yan Sun; Wei Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

Review 6.  The pharmacogenomics of valproic acid.

Authors:  Miao-Miao Zhu; Hui-Lan Li; Li-Hong Shi; Xiao-Ping Chen; Jia Luo; Zan-Ling Zhang
Journal:  J Hum Genet       Date:  2017-09-07       Impact factor: 3.172

Review 7.  Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy.

Authors:  Hadas Han; Aniv Mann; Dana Ekstein; Sara Eyal
Journal:  AAPS J       Date:  2017-05-26       Impact factor: 4.009

Review 8.  Pharmacologic approaches to HIV-associated neurocognitive disorders.

Authors:  Sean N Avedissian; Shetty Ravi Dyavar; Howard S Fox; Courtney V Fletcher
Journal:  Curr Opin Pharmacol       Date:  2020-10-10       Impact factor: 5.547

9.  Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy.

Authors:  Tracy A Glauser; Katherine Holland; Valerie P O'Brien; Mehdi Keddache; Lisa J Martin; Peggy O Clark; Avital Cnaan; Dennis Dlugos; Deborah G Hirtz; Shlomo Shinnar; Gregory Grabowski
Journal:  Ann Neurol       Date:  2017-03       Impact factor: 10.422

Review 10.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.